Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-23 Sale | 2026-02-25 6:20 pm | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 20,056 | $8.28 | $166,064 | 3,313,137 (Indirect Direct) | View |
| 2026-02-23 Sale | 2026-02-25 6:19 pm | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 2,810 | $8.28 | $23,267 | 269,108 (Direct) | View |
| 2026-02-23 Sale | 2026-02-25 6:18 pm | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 3,057 | $8.28 | $25,312 | 323,368 (Direct) | View |
| 2026-02-23 Sale | 2026-02-25 6:17 pm | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 1,759 | $8.28 | $14,565 | 330,653 (Direct) | View |
| 2026-02-20 Sale | 2026-02-24 6:13 pm | OCULAR THERAPEUTIX INC | OCUL | Waheed Nadia Chief Medical Officer | 3,510 | $7.74 | $27,167 | 314,907 (Direct) | View |
| 2026-02-20 Purchase | 2026-02-24 6:13 pm | OCULAR THERAPEUTIX INC | OCUL | LINDSTROM RICHARD L MD Director | 60,229 | $7.66 | $461,354 | 246,933 (Direct) | View |
| 2026-02-12 Sale | 2026-02-17 8:31 pm | OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Operating Officer | 11,446 | $9.04 | $103,472 | 366,356 (Direct) | View |
| 2026-02-12 Sale | 2026-02-17 8:30 pm | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 10,348 | $9.04 | $93,546 | 332,412 (Direct) | View |
| 2026-02-12 Sale | 2026-02-17 8:29 pm | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 124,882 | $9.04 | $1,128,933 | 3,333,193 (Indirect Direct) | View |
| 2026-02-12 Sale | 2026-02-17 8:28 pm | OCULAR THERAPEUTIX INC | OCUL | Waheed Nadia Chief Medical Officer | 7,863 | $9.04 | $71,082 | 318,417 (Direct) | View |
| 2026-02-02 Sale | 2026-02-04 8:23 pm | OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Operating Officer | 11,490 | $8.8249 | $101,398 | 377,802 (Direct) | View |
| 2025-11-24 Sale | 2025-11-26 4:02 pm | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 1,878 | $12.04 | $22,611 | 277,860 (Direct) | View |
| 2025-11-24 Sale | 2025-11-26 4:02 pm | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 19,530 | $12.04 | $235,141 | 3,458,075 (Indirect Direct) | View |
| 2025-11-24 Sale | 2025-11-26 4:01 pm | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 3,007 | $12.02 | $36,144 | 191,433 (Direct) | View |
| 2025-11-24 Sale | 2025-11-26 4:01 pm | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 3,469 | $12.04 | $41,767 | 245,940 (Direct) | View |
| 2025-11-05 Sale | 2025-11-07 4:01 pm | OCULAR THERAPEUTIX INC | OCUL | Saroj Namrata Chief Business Officer | 25,865 | $10.74 | $277,790 | 174,135 (Direct) | View |
| 2025-10-08 Sale | 2025-10-10 4:01 pm | OCULAR THERAPEUTIX INC | OCUL | Anderman Todd Chief Legal Officer | 11,132 | $12.34 | $137,369 | 87,568 (Direct) | View |
| 2025-10-02 Sale | 2025-10-06 5:13 pm | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 9,653 | $11.03 | $106,473 | 194,440 (Direct) | View |
| 2025-10-02 Sale | 2025-10-06 5:10 pm | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 10,502 | $11.04 | $115,942 | 249,409 (Direct) | View |
| 2025-09-02 Sale | 2025-09-04 4:50 pm | OCULAR THERAPEUTIX INC | OCUL | Notman Donald See Remarks | 1,066 | $12.43 | $13,250 | 308,807 (Direct) | View |
| 2025-08-25 Sale | 2025-08-27 6:44 pm | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 3,011 | $12.04 | $36,252 | 204,093 (Direct) | View |
| 2025-08-25 Sale | 2025-08-27 6:43 pm | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 1,885 | $12.04 | $22,695 | 279,738 (Direct) | View |
| 2025-08-25 Sale | 2025-08-27 6:42 pm | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 3,063 | $12.04 | $36,879 | 259,911 (Direct) | View |
| 2025-08-25 Sale | 2025-08-27 6:41 pm | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 21,494 | $12.04 | $258,788 | 3,477,605 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-21 Option Award | 2026-01-26 7:15 pm | N/A 2036-01-20 | OCULAR THERAPEUTIX INC | OCUL | Robinson David Wayne Global CCO | 552,000 | $0 | 552,000 (Direct) | View |
| 2026-01-20 Option Award | 2026-01-22 6:41 pm | N/A 2036-01-19 | OCULAR THERAPEUTIX INC | OCUL | Robins Jason Shand Interim CFO | 33,000 | $0 | 33,000 (Direct) | View |
Ownership | 2026-01-22 6:39 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Robins Jason Shand Interim CFO | 0 | $0 | 231,451 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:07 pm | N/A 2036-01-01 | OCULAR THERAPEUTIX INC | OCUL | Anderman Todd Chief Legal Officer | 262,550 | $0 | 350,118 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:06 pm | N/A 2036-01-01 | OCULAR THERAPEUTIX INC | OCUL | Meyers Steve Lawrence Chief Commercial Officer | 262,550 | $0 | 415,278 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:06 pm | N/A 2036-01-01 | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 262,550 | $0 | 540,410 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:05 pm | N/A 2036-01-01 | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 320,044 | $0 | 512,850 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:04 pm | N/A 2036-01-01 | OCULAR THERAPEUTIX INC | OCUL | Saroj Namrata Chief Business Officer | 320,044 | $0 | 495,552 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:04 pm | N/A 2036-01-01 | OCULAR THERAPEUTIX INC | OCUL | Waheed Nadia Chief Medical Officer | 320,044 | $0 | 567,212 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:03 pm | N/A 2036-01-01 | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 320,044 | $0 | 567,357 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:01 pm | N/A 2036-01-01 | OCULAR THERAPEUTIX INC | OCUL | Notman Donald See Remarks | 320,044 | $0 | 630,224 (Direct) | View |
| 2025-11-26 Gift | 2025-11-26 4:02 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 49,754 | $0 | 3,458,075 (Indirect) | View |
| 2025-09-09 Gift | 2025-09-11 4:06 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 49,754 | $0 | 3,477,605 (Direct) | View |
| 2025-08-12 Option Award | 2025-08-14 5:51 pm | N/A 2035-08-11 | OCULAR THERAPEUTIX INC | OCUL | Waheed Nadia Chief Medical Officer | 163,286 | $0 | 370,091 (Direct) | View |
| 2025-04-28 Gift | 2025-08-13 7:02 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 500,722 | $0 | 3,499,099 (Direct) | View |
Ownership | 2025-06-23 9:12 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Meyers Steve Lawrence Chief Commercial Officer | 0 | $0 | 664,728 (Direct) | View |